Psilocybin Detection Window in the Body
Psilocybin and its active metabolite psilocin are rapidly eliminated from the body, with detection possible in urine for approximately 24 hours after use, in blood for up to 12 hours, and in saliva for 24-48 hours.
Pharmacokinetic Profile
Psilocybin acts as a prodrug that is rapidly dephosphorylated to psilocin, the pharmacologically active compound. After oral administration, psilocin reaches peak plasma concentrations (Tmax) between 1.8-4 hours 1, 2. The elimination half-life of psilocin ranges from 1.4-4.72 hours across studies 1, 2, with most studies clustering around 1.5-2 hours.
The volume of distribution is extensive (277-1267 L), indicating significant tissue distribution 1, 3. Only 1.5-3.4% of the administered dose is excreted unchanged as psilocin in urine 1. The majority undergoes hepatic metabolism via CYP2D6 and CYP3A4 to 4-hydroxyindole-3-acetic acid (4HIAA) and 4-hydroxytryptophol 3.
Detection Windows by Specimen Type
Blood/Plasma
- Detection window: 2-12 hours after use 4
- Most useful for detecting very recent use
- Psilocin concentrations decline rapidly given the short half-life
Urine
- Detection window: Approximately 24 hours for single-dose use
- Psilocin is present primarily as psilocin-glucuronide conjugate 5
- Critical caveat: Standard urine drug screens do NOT typically test for psilocybin/psilocin
- Specialized testing requires enzymatic hydrolysis with β-glucuronidase followed by derivatization for GC/MS detection 5
- Limit of quantitation: 10 ng/mL with optimized methods 5
- Without hydrolysis and derivatization, detection limit is only 200 ng/mL 5
Saliva/Oral Fluid
- Detection window: 24-48 hours 4
- Detects recent use that may not yet appear in urine
- Less standardized than blood or urine testing 4
Hair
- Not practical for psilocybin detection
- Cannot detect use within previous 7-10 days 4
- Most reliable only for heavy, frequent past use over extended periods (90+ days) 4
Important Clinical Considerations
The subjective psychoactive effects last considerably longer than detectable drug levels: mean duration of subjective effects is 5.5-6.4 hours 2, while plasma psilocin becomes undetectable much sooner. This disconnect between pharmacokinetics and pharmacodynamics is clinically relevant.
Standard workplace or clinical drug screens do not detect psilocybin/psilocin - specialized testing with specific methodology is required 5. The compound requires enzymatic hydrolysis to detect the glucuronide conjugate, which is the primary urinary form.
No food effects or significant covariate influences have been identified on psilocin pharmacokinetics 1, and body weight does not appear to influence the pharmacokinetic profile or response 2.
The rapid elimination profile means that for most practical purposes, psilocybin/psilocin is undetectable in standard biological matrices beyond 24-48 hours after a single use, making it one of the shortest detection windows among commonly used psychoactive substances 6.